Revise Notes Opthal Flashcards
Age Related Macular Degeneration
Pathophysiology
A leading cause of visual loss and blindness in middle-aged/older adults (50s-60s)
It results from a combination of non-vascular and neovascular changes to the retina with resultant visual impairment.
Non-vascular:
Drusen formation - dome-shaped yellow deposits composed of protein/lipids which accumulate beneath the retinal pigment epithelium
Retinal pigment epithelium abnormalities
Hyper and hypopigmentation
Geographic atrophy - well demarcated areas of depigmentation which occurs due to degeneration of the light-sensitive macular cells.
Vascular:
Choroidal neovascularisation (wet ARMD)
AMD can be classified as wet or dry. Wet ARMD is defined by the presence of neovascularisation
Newly formed vessels are fragile and susceptible to rupture and leakage which results in scarring of the retina
Clinical features
Symptoms
Impaired visual acuity - can be insidious or rapidly progressive (normally due to neovascular AMD)
Blurred vision
Distorted near vision, including metamorphopsia (where straight lines appear wobbly)
Identified using amsler grid
Central scotoma - central visual fields are absent, ‘a black patch’
Hallucinations - AMD is a common cause of Charles Bonnet syndrome
Examination/fundoscopy findings
Drusen
Macular changes - pigmentary/atrophic/haemorrhagic
Ardm
Investigation and mng
Investigations
Optical coherence tomography - mandatory for diagnosis and monitoring treatment response - high resolution cross sectional imaging of the retina to look for RPE changes/drusen etc.
Fluorescein angiography - to identify the presence of neovascularisation
Management
Non-exudative AMD
Risk factor modification - smoking cessation
Nutritional supplementation - antioxidants (AREDS treatment) - contains beta-carotene (metabolised into vitamin A), vitamins C & E, zinc, copper
Beta-carotene can increase risk of lung cancer in smokers
Exudative AMD
Intravitreal anti-vascular endothelial growth factor (VEGF) injections
Laser treatments
Blepharitis
Background
Chronic inflammation of the margin of the eyelids, usually bilateral
Anterior – base of eyelashes are inflamed. Causes include:
Infective blepharitis - staph. aureus most common
Seborrheic blepharitis
Posterior – Meibomian glands (MG) inflammation
Cause: MG dysfunction - The MGs are located on the posterior margin of the eyelid and secrete an oily/ lipid secretion onto the cornea/ conjunctiva, which helps form the tear film -
prevents tear evaporation, maintains smooths eye surface
Clinical features
Symptoms
Itchy, ‘burning’ discomfort of eyelids
Eyelid can be crusty and stick together, especially in the mornings
Bilateral symptoms
Symptoms are often intermittent with periods of exacerbation and remission
Examination Findings
Staphylococcal
Crusting at base of eyelashes, with eyelid erythema/inflammation
May be history of styes
Seborrhoeic
Oily skin, scaly dermatitis, erythema/inflammation of lids
MGD
Foamy discharge can be seen on the eyelid margin, chalazion are often present
Mng of blepharitis
Management
1st line: Self-care measures - warm compress and hygiene measures
Also, if co-existent dry eye disease - consider artificial tears/ocular lubricant
2nd line: If self-care measures are ineffective
Anterior blepharitis - consider topical ABx (chloramphenicol) for eyelid margins
Posterior blepharitis - If MGD in the context of rosacea - PO tetracycline (doxy/oxy)
Cataracts
Pathophysiology
The cloudy opacification of the crystalline lens of the eye, with resultant visual impairment.
Most are age related, and can occur uni- or bilaterally
Subtypes:
Nuclear - the centre of the lens becomes opacified - agein
Polar - localised opacification - often genetic
Subcapsular - anterior or posterior subcapsular cortex - assoc. w/ steroid
Clinical features
Mostly occur in patients > 60 yrs as a consequence of ageing
Symptoms
Gradual, progressive loss of visual acuity/ blurring of vision
Fading colour vision, especially blues
Glare and ‘halos’ reported around lights
Impaired night vision
Examination Findings
Leukocoria - grey/white discolouration of the pupil
Loss of red reflex
Investigations
Slit lamp examination to examine the lens and visualise cataract
Management of cataract
Surgery - Phacoemulsification
Complications:
Posterior capsular thickening is the most common post-op complication, affecting 20% of patients.
Cells remaining post-operatively grow back over the posterior lens capsule.
This results in reduced light transmission to the retina. Patients may report cloudy/blurred vision and difficulty seeing at night.
Glare is another suggestive symptom.
Endophthalmitis: Post-operative infection, presenting with pain, redness and photophobia.
Chalazion
Pathophysiology
A chalazion (meibomian cyst) is a sterile, inflammatory granuloma.
It is caused by the obstruction of the sebaceous meibomian glands which enlarges, and then ruptures.
The ruptured gland releases its lipid contents (a component of the tear film) which triggers an inflammatory reaction, and results in the formation of a granuloma.
Clinical features
Symptoms
A firm, localised swelling of one of the eyelids which develops over several weeks
Usually painless/non-tender (although might have been sore initially)
Differential diagnosis: Hordeola - usually develop more acutely, and are more painful
Examination Findings
Unilateral swollen, erythematous eyelid
Firm nodule may be felt, non-tender
Most commonly affect the upper eyelid
A well-defined nodule (the granuloma) can be identified with eversion of the eyelid
Chalazion mng
Management
Self-care measures: Warm compress and gentle massage to aid content expression
Chalazions usually self-resolve spontaneously within a few weeks
If no improvement after 1 month,
consider referral to ophthalmologist for consideration of incision/curettage or intralesional steroid injection
Conjunctivitis
Background
Inflammation of the thin, transparent, mucous membrane lining the anterior sclera, and palpebral conjunctiva.
Clinical features: Hyperaemia and dilation of conjunctival vessels +/- discharge
Allergic conjunctivitis
Ocular IgE hypersensitivity reaction. Allergens bind to mast cells which release histamine and inflammatory mediators.
Common causes include:
Seasonal allergic conjunctivitis (hay fever)
Perennial AC – dust mites/ mould spores/ animal dander
Clinical features:
Bilateral itchy eyes
May be a watery discharge/tearing
Conjunctival inflammation -
hyperaemia, oedema, dilated vessels
May be a history of asthma/eczema/rhinosinusitis
Management:
Initial management - non-pharmacological measures:
Allergen avoidance, cold compress etc.
If non-pharmacological Mx does not provide sufficient symptomatic relief:
Topical antihistamine or mast cell stabilisers - azelastine, sodium cromoglicate etc.
Topical AHs have been found to be more effective than PO/systemic AHs for relief of ocular symptoms
Infective conjunctivitis
Causes
Viral
Adenovirus is the most common cause
May be a history of URTI
Herpes simplex virus - unilateral red eye, with vesicular lesions on eyelid
Bacterial
Streptococcus pneumoniae is most common
Others: chlamydia, gonorrhoea
History of STI/unprotected sex
Clinical features
Clinical features
Acute, bilateral conjunctival erythema
Gritty, foreign body sensation
Discharge
Often purulent with crusting in bacterial conjunctivitis, lids may crust and stick together on waking up.
Less discharge in viral conjunctivitis, which is usually watery
Mng of conjunctivitis
Management
Refer to ophthalmology if suspected:
Ophthalmia neonatorum - conjunctivitis in first 4 weeks
Suspected gonococcal / chlamydial conjunctivitis
Suspected herpes conjunctivitis
Viral conjunctivitis
Most cases resolve within 2 weeks without treatment
Bacterial conjunctivitis
Most cases self-resolve within 1 week, without treatment
Consider topical antibiotics (chloramphenicol/fusidic acid) if severe symptoms
Retinal detachment
Pathophysiology
Retinal detachment occurs when the inner neurosensory retina separates from the outer retinal pigment epithelium (RPE), disrupting retinal function.
Types include rhegmatogenous (due to retinal tears or holes), tractional (from fibrous tissue pulling the retina), and exudative (from fluid accumulation under the retina).
Clinical Features
Painless
Visual impairment - feeling of dots, cobwebs or a curtain passing over the eye
New onset photopsias, flashes of light or persistent new floaters suggest a retinal tear, which can be followed by retinal detachment
Detachment is suggested by a progressive loss of vision - often described as a dense shadow, which starts peripherally and moves centrally.
Fundoscopy - pale, opaque retina often with wrinkling and loss of the normal choroidal pattern
Management
Ophthalmological emergency - requiring immediate referral.
Slit lamp examination should be performed.
Retinitis pigmentosa
Pathophysiology
Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterised by progressive photoreceptor degeneration, primarily affecting rods and later cones.
Genetic mutations lead to the gradual loss of retinal cells, resulting in vision impairment.
Clinical Features
Night blindness (nyctalopia) is often the initial symptom.
Progressive peripheral visual field loss, leading to tunnel vision.
Photopsias (flashes of light) and difficulty with dark adaptation.
Central vision loss occurs in advanced stages.
Fundoscopy: Bone-spicule black pigmentation predominantly affecting the peripheral retina, attenuated retinal vessels, and optic disc pallor.
Management
There is no cure for RP. Management focuses on maximising remaining vision and improving quality of life.
Supportive Care: Low vision aids, mobility training, and psychological support.
Monitoring: Regular ophthalmic evaluations to monitor disease progression.
Emerging Therapies: Participation in clinical trials for gene therapy and retinal implants.
Central retinal vein occlusion
CRVO results from thrombosis in the central retinal vein, causing retinal congestion and haemorrhage.
Risk factors include hypertension, diabetes, glaucoma, and hypercoagulable states.
Clinical features
Sudden, painless unilateral loss of vision, may be partial or complete.
Fundoscopy: Retinal haemorrhages, dilated tortuous veins, and cotton-wool spots
Central retinal vein occlusion
Figure 165: Central retinal vein occlusion. Werner JU, Böhm F, Lang GE, Dreyhaupt J, Lang GK, Enders C, Fondo de ojo Ostrucción Vena central, CC BY 4.0
Central retinal artery occlusion (thromboembolism, arteritis)
CRAO occurs due to embolic or thrombotic obstruction of the central retinal artery,
leading to retinal ischaemia.
Common causes include atherosclerosis and emboli from carotid artery disease or cardiac sources
.
Clinical features
Sudden, painless unilateral loss of vision
O/E: RAPD may be present.
Fundoscopy: Cherry red spot on pale retina
Figure 166: Central retinal artery occlusion- Cherry red spot and retinal swelling.
Dr. Gopal Bisht, Cherry red spot in patient with central retinal artery occlusion (CRAO), CC BY-SA 4.0
Hyertensive retinopathy vs DM retinopathy
Hypertensive retinopathy is characterised by the following
:
Arteriolar narrowing
Arteriovenous nipping
Cotton wool spots/haemorrhages
Papilloedema
Diabetic Eye Disease
Diabetic eye disease is the most common cause of blindness in patients aged 30-65 yrs.
Screening for eye disease
Patients with type 1 and type 2 diabetes should have annual screening for diabetic eye disease (except T2DM with very low risk - no retinopathy on last 2 x screening tests, where screening may be biannual).
Staging of diabetic eye disease
Stage 1: Mild Non-Proliferative Diabetic Retinopathy (NPDR)
Microaneurysms present
Stage 2: Moderate NPDR
Blot haemorrhages
Exudates
Cotton wool spots
Venous looping
Stage 3: Severe NPDR
Dots and blots in all 4 quadrants with venous beading in 2 or more quadrants and intraretinal microvascular abnormality (IRMA) in 1 or more quadrants